Trial Profile
Safety and efficacy of TRC150094 in treatment of cardio-metabolic risk in overweight/obese pre-diabetic subjects with dyslipidemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2016
Price :
$35
*
At a glance
- Drugs Omzotirome (Primary)
- Indications Cardiovascular disorders; Dyslipidaemias
- Focus Therapeutic Use
- Sponsors Torrent Pharmaceuticals
- 16 Apr 2013 New trial record